Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Introduction: A coding variant in the TLR4 receptor (rs4986790), previously associated with longevity and Alzheimer's disease (AD) risk reduction, was examined in a population isolate (Québec Founder Population [QFP]) and in presymptomatic individuals with a parental history of AD (Pre‐Symptomatic Evaluation of Novel or Experimental Treatment for Alzheimer's Disease [PREVENT‐AD]). Methods: Genotyping was performed using the Illumina HumanHap 550k (QFP) and the Illumina Omni2.5 beadchips (PREVENT‐AD). Cognition was assessed using the Repeatable Battery for Assessment of Neuropsychological Status (RBANS). Whole‐brain cortical thickness data were analyzed using CIVET 1.12. Cerebrospinal fluid concentrations of cytokines were obtained by using Milliplex. Results: The minor allele of the rs4986790 polymorphism (G) is associated with a reduced risk of developing AD in the QFP, as well as higher visuospatial and constructional abilities, higher cortical thickness in visual‐related regions, and stable cerebrospinal fluid IL‐1β levels in the PREVENT‐AD cohort. Discussion: The rs4986790 G coding variant in the TLR4 gene appears to reduce AD risk through the modulation of IL‐1β synthesis and secretion in the presymptomatic phase of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519 · cited 1×
“It measures 5 domains of cognitive performance [24].”
BackgroundDiagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499 · cited 4×
“Autopsied brains from the QFP, on the other hand, had to fulfill the histopathological National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association criteria for a definite diagnosis of AD [21].”
BackgroundMethodInfluentialAlzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202 · cited 3×
“When further investigating the interaction between the rs4986790 genotypes and time of visits, CSF IL-1b levels are different between AA and AG carriers at the 12-month time point (t [9]5 1.”
BackgroundVaure, C., & Liu, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00316 · Cited by 842
Ball, M. J. (1977) · Acta Neuropathologica · doi:10.1007/bf00692056 · Cited by 639 · cited 1×
“Alzheimer’s disease (AD) pathology is characterized by extracellular amyloid plaques [1], neuronal and synaptic loss [2,3], intraneuronal neurofibrillary tangles [4], cortical thinning in the temporal, orbitofrontal, and parietal regions [5], and chronic inflammation [6].”
BackgroundDavies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628
Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease
Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., et al. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110455 · Cited by 543
Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100620 · Cited by 473 · cited 2×
“Furthermore, inhibition with a blocking antibody of the receptor for IL-1b, namely IL-1R, in the 3x-Tg AD mouse model rescued hippocampus-dependent cognitive impairments, decreased amyloid plaque load, and reduced levels of brain insoluble Ab42, oligomeric Ab species, and phosphorylated Tau [49].”
BackgroundBrosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
THE FINE STRUCTURE OF NEUROFIBRILLARY TANGLES IN ALZHEIMERʼS DISEASE
Terry, R. D. (1963) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196310000-00005 · Cited by 403
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer’s disease
Singh, V., Chertkow, H., Lerch, J. P., Evans, A. C., Dorr, A. E., & Kabani, N. J. (2006) · Brain · doi:10.1093/brain/awl256 · Cited by 386
On the right side? A longitudinal study of left- versus right-lateralized semantic dementia
Kumfor, F., Landin-Romero, R., Devenney, E., Hutchings, R., Grasso, R., Hodges, J. R., & Piguet, O. (2016) · Brain · doi:10.1093/brain/awv387 · Cited by 224
Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study
Walker, K. A., Hoogeveen, R. C., Folsom, A. R., Ballantyne, C. M., Knopman, D. S., Windham, B. G., Jack, C. R., & Gottesman, R. F. (2017) · Neurology · doi:10.1212/wnl.0000000000004688 · Cited by 150 · cited 2×
“All ri an association of inflammatory markers at midlife with worst performance on a word-recall test and lower brain volume in pathology-affected regions in AD [7].”
BackgroundSchultz, S. A., Oh, J. M., Koscik, R. L., Dowling, N. M., Gallagher, C. L., Carlsson, C. M., Bendlin, B. B., LaRue, A., Hermann, B. P., Rowley, H. A., et al. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.010 · Cited by 117 · cited 1×
“Cortical thinning in the fusiform gyrus is positively correlated with Braak neurofibrillary tangle staging [43] and is present in middle-aged adults with subjective memory complaints [44].”
BackgroundFrank, S., Copanaki, E., Burbach, G. J., Müller, U. C., & Deller, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.075 · Cited by 86 · cited 1×
“Among the numerous actors implicated in the inflammatory process in AD, TLR4 has been identified as an important link between AD pathological processes and the downstream release of proinflammatory cytokines in both mouse models of AD [11,12,14,27] and in human diseased brains [28].”
Background
Cited by
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
“AD), demonstrating the association of the TLR4 variant with a reduced AD risk, better visuospatial and constructional skills, an increased cortical thickness in visual cortices, and stable IL-1β levels in cerebrospinal fluid (CSF) over time (73).”
BackgroundAnti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
Zhang, C., Fan, Y., Che, X., Zhang, M., Li, Z., Li, C., Wang, S., Wen, T., Hou, K., Shao, X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00760 · Cited by 69
“Detection of Several Cytokines The MILLIPLEX magnetic bead assay (29) was used as per manufacturer’s instructions (Millipore) to measure cytokines secretion from activated CD8+ T cells and Co-inhibitory or costimulatory factors of Immune Checkpoint protein via patients’ serum.”
MethodA small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
Balu, D., Valencia-Olvera, A. C., Nguyen, A., Patnam, M., York, J., Peri, F., Neumann, F., LaDu, M. J., & Tai, L. M. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01330-6 · Cited by 27
Heneghan, A., Deng, F., Wells, K., Ritchie, K., Muniz-Terrera, G., Ritchie, C. W., Lawlor, B., & Naci, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220267 · Cited by 18
Liu, J., Lin, Y., Yang, Y., Guo, Y., Shang, Y., Zhou, B., Liu, T., Fan, J., & Wei, C. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115149 · Cited by 12
Metadata
- Authors
- Miron, J., Picard, C., Lafaille‐Magnan, M., Savard, M., Labonté, A., Breitner, J., Rosa‐Neto, P., Auld, D., Poirier, J., & for the PREVENT‐AD research group
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2019-06-04
- Volume
- 15
- Issue
- 7
- Pages
- 951-960
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2948881719
- Cited by
- 37
- References
- 16
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.